The Alzheimer's Lie: Unmasking Decades of Deliberate Fraud | Multi Level Mondays
iilluminaughtii
00:00
The First Treatment for Alzheimer's Is Here
BioGem made a duke-a-namob to treat the protein plaques associated with Alzheimer's. The FDA approved it too in mid-2021, but not everyone was so hopeful at first. Adjuhelm caused quite a bit of controversy, to the point where three FDA advisors resigned over its approval. Over the last two decades, Alzheimer's drugs have mostly been notable for having a 99% failure rate in human trials.
Transcript
Play full episode
